ro 15-0216 has been researched along with amsacrine in 1 studies
*Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent. [MeSH]
*Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent. [MeSH]
| Studies (ro 15-0216) | Trials (ro 15-0216) | Recent Studies (post-2010) (ro 15-0216) | Studies (amsacrine) | Trials (amsacrine) | Recent Studies (post-2010) (amsacrine) |
|---|---|---|---|---|---|
| 12 | 0 | 0 | 1,293 | 127 | 120 |
| Protein | Taxonomy | ro 15-0216 (IC50) | amsacrine (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 1 | Homo sapiens (human) | 5 | |
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | 7.43 | |
| DNA topoisomerase 2-alpha | Homo sapiens (human) | 5.47 | |
| 5-hydroxytryptamine receptor 7 | Cavia porcellus (domestic guinea pig) | 5 | |
| DNA topoisomerase 2-beta | Homo sapiens (human) | 1.88 | |
| Aldehyde oxidase | Homo sapiens (human) | 3.2 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.2095 | |
| Aldehyde oxidase 1 | Rattus norvegicus (Norway rat) | 6.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alsner, J; Andersen, AH; Jensen, PB; Sinding, J; Sørensen, BS; Westergaard, O | 1 |
1 other study(ies) available for ro 15-0216 and amsacrine
| Article | Year |
|---|---|
Mode of action of topoisomerase II-targeting agents at a specific DNA sequence. Uncoupling the DNA binding, cleavage and religation events.
Topics: Acetanilides; Aclarubicin; Amsacrine; Animals; Base Sequence; Cattle; DNA Topoisomerases, Type II; Molecular Sequence Data; Nitroimidazoles; Nucleic Acid Conformation; Nucleic Acid Hybridization; Oligodeoxyribonucleotides; Thymus Gland; Topoisomerase II Inhibitors; Trypanocidal Agents | 1992 |